TRIA-002

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameTRIA-002

Drug Alias NameDual B7H Family Member Checkpoint Inhibitor/4-1BB Costimulator (TRIGR Therapeutics)TRIA-02TRIA-002

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 agonistsT lymphocytes stimulantsImmunostimulants

TargetsTumor necrosis factor receptor superfamily member 9

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTrigr Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTrigr Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A